Open tender · Germany · Pharmaceutical products
Abschluss eines nicht exklusiven Rabattvertrages nach § 130a Abs. 8 SGB V zu Arzneimitteln mit der Wirkstoffkombination aus Emtricitabin, Rilpivirin und Tenofovirdisoproxil (ATC-Code J05AR08)
In EnglishConclusion of a non-exclusive rebate contract pursuant to Section 130a Paragraph 8 SGB V for pharmaceutical products with the active ingredient combination of emtricitabine, rilpivirine and tenofovir disoproxil (ATC code J05AR08)
AOK Niedersachsen. Die Gesundheitskasse.
AOK Niedersachsen. Die Gesundheitskasse. in Germany is inviting bids for “Conclusion of a non-exclusive rebate contract pursuant to Section 130a Paragraph 8 SGB V for pharmaceutical products with the active ingredient…”. Bids close on 25 January 2027, 12:00 CET. askTender lists every requirement to qualify and checks whether your company meets them.
The work
Abschluss eines nicht exklusiven Rabattvertrages für Arzneimittel mit Wirkstoffkombination Emtricitabin, Rilpivirin und Tenofovirdisoproxil (ATC-Code J05AR08).
Key facts
- Procedure
- Contract notice
Before you bid, askTender
Everything else is in your askTender account
askTender has broken this tender down into 3 requirements to qualify (1 on experience, 2 certifications and registrations) and the 1 document a bidder must file.
- What it takes to qualify: every requirement, in the tender’s own words
- Whether your company qualifies: your profile checked against each requirement, showing what you have, what’s missing and how to close the gap
- The documents to file: a checklist, with draft declarations ready to sign
- A bid partner for any requirement you can’t meet alone
- The tender documents, ready to open
- Alerts for new tenders like this one
Public data: TED – Tenders Electronic Daily. © European Union, 1998–2026. Notices reused under Commission Decision 2011/833/EU. · Sources & licences